Abiomed's heart pump gets EU nod

Thu Apr 12, 2012 6:30pm IST

A zoomed picture shows two surgeons performing an operation to implant an artificial heart valve in the operating room of a Berlin hospital August 15, 2003. REUTERS/Fabrizio Bensch

A zoomed picture shows two surgeons performing an operation to implant an artificial heart valve in the operating room of a Berlin hospital August 15, 2003.

Credit: Reuters/Fabrizio Bensch

Related Topics

Stocks

   

(Reuters) - Abiomed Inc said European health regulators approved the use of its heart pump in cardiac surgery.

The Danvers, Massachusetts-based company said the device, called Impella cVAD, is expected to be commercially available in Europe by this summer.

The device is intended for use in cardiac surgery for supporting the weakened heart's left ventricle, which is responsible for pumping oxygen-rich blood from the lungs throughout the body.

Impella cVAD is still not approved in the United States.

Abiomed shares closed at $20.90 on Wednesday on the Nasdaq.

(Reporting by Anand Basu in Bangalore; Editing by Viraj Nair)

FILED UNDER:

Ebola Fight

REUTERS SHOWCASE

Nifty Above 8,600

Nifty Above 8,600

Nifty hits record high above 8,600; state-run lenders gain  Full Article 

Bhopal Tragedy

Bhopal Tragedy

Bhopal's toxic legacy lives on, 30 years after industrial disaster  Full Article 

Essar Group

Essar Group

Exclusive - Essar's planned oil-for-steel deal tests Iran sanctions  Full Article 

Islamic Fund

Islamic Fund

India gets new Islamic equity fund but debt market still off-limits  Full Article 

Fiscal Deficit

Fiscal Deficit

April-October fiscal deficit nears 90 pct of full-year target  Full Article 

Oil Prices

Oil Prices

Oil hits new four-year low post OPEC as glut looms  Full Article 

Gold Imports

Gold Imports

Nov gold imports seen climbing on expectation of curbs   Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage